Does the course of Val122Ile differ from SSA, or is selection bias a factor?

Orphanet J Rare Dis · 2015 · PMC4642087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Actuarial survival from diagnosis did not differ between groups, being 33 months in Val122Ile and 36 months in SSA, but there was a a strong trend to better survival from symptom onset in SSA (66 months in SSA v 51 months in Val122Ile).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.